title: The role of pharmacogenetics in the new ESMO colorectal cancer guidelines.
authors.affiliation: Oncologia Medica 1, Istituto Oncologico Veneto, IRCCS Padova, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Schirripa
authors.affiliation: Oncologia Medica 1, Istituto Oncologico Veneto, IRCCS Padova, Italy.
authors.forename: Letizia
authors.initials: L
authors.lastname: Procaccio
authors.affiliation: Oncologia Medica 1, Istituto Oncologico Veneto, IRCCS Padova, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Lonardi
authors.affiliation: Oncologia Medica 1, Istituto Oncologico Veneto, IRCCS Padova, Italy.
authors.forename: Fotios
authors.initials: F
authors.lastname: Loupakis
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods; D020641:Polymorphism, Single Nucleotide / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor
keywords: DPD; ERCC1; UGT; colorectal cancer; pharmacogenetic